Compounded Semaglutide vs Wegovy: Cost, Safety, and Sourcing Compared

Same Active Ingredient, Two Different Products

If you have looked into semaglutide for weight loss, you have probably noticed two very different prices floating around. Branded Wegovy, the FDA-approved obesity treatment from Novo Nordisk, typically lands somewhere between $1,000 and $1,800 per month cash pay. A compounded semaglutide program from a US-licensed compounding pharmacy can be a fraction of that. The active ingredient is the same molecule. The packaging, regulatory pathway, and supply chain are not.

This guide is the honest comparison we wish more sources offered. Wegovy has real advantages. Legitimate compounded semaglutide has real advantages too. There is also a grey-market layer of overseas, research-only, and unlicensed sellers that should be avoided regardless of price. We will lay out the differences in cost, safety, sourcing, and dosing.

What "Compounded" Actually Means

A compounded medication is a preparation made by a state-licensed compounding pharmacy for a specific patient based on a prescription from a licensed provider. Compounding is a legitimate, regulated branch of pharmacy that exists to address shortages, allergy needs, alternate dosing, and personalized formulations. It is not generic manufacturing. It is patient-specific preparation by a US-licensed compounding pharmacy that is subject to state board oversight and, for larger facilities, federal 503A or 503B rules.

Compounded semaglutide is studied in research as having a similar pharmacologic profile to branded semaglutide because it uses the same semaglutide base. Compounded medications are not FDA-approved drugs, however. That distinction matters and we will come back to it.

Cost: The Numbers Most People Are Comparing

The price gap is the headline reason patients consider a compounded option, and it is real.

Why the difference exists in plain terms: branded Wegovy carries the cost of the original semaglutide research program, manufacturer profit margin, marketing, and traditional distribution. A compounded preparation skips most of that. The pharmacy is still buying semaglutide base, performing quality testing, and dispensing under licensure, but the layered overhead is much smaller.

One important note about cost. Cheap is not always legitimate. A $99 a month "semaglutide" listing that does not require a prescription or a licensed-provider evaluation is almost certainly not coming from a US-licensed compounding pharmacy.

Safety: What Is and Is Not the Same

Branded Wegovy was studied in the STEP clinical trial program, which generated the efficacy and safety data the FDA used to approve it for chronic weight management. That trial backbone is a genuine advantage. You know exactly what was tested, in whom, and what events occurred.

Compounded semaglutide, when prepared by a US-licensed compounding pharmacy from pharmaceutical-grade semaglutide base, uses the same active molecule that was studied in those trials. Side effect profile in clinical practice has been broadly similar to branded products at equivalent doses. Common effects are gastrointestinal, including nausea, reflux, constipation, and reduced appetite, especially during dose escalation. Boxed warnings for medullary thyroid carcinoma risk and contraindications such as MEN 2 apply to either form, because the molecule is the same.

Where compounded preparations differ on safety:

• No FDA pre-market review. Compounded medications are not FDA-approved drugs. State boards of pharmacy and, for 503B outsourcing facilities, the FDA inspect the pharmacy. They do not approve the specific compounded preparation the way they approve a brand.
• Variability is possible across pharmacies. One US-licensed compounding pharmacy is not interchangeable with another. Sourcing of semaglutide base, quality testing, and aseptic technique vary. Reputable pharmacies publish their certifications and testing protocols.
• Salt forms and additives. Some early compounded products on the market in 2023 and 2024 used semaglutide sodium and semaglutide acetate, which are not the same as the semaglutide base used in branded products. The FDA flagged this. A legitimate compounded semaglutide program in 2026 should use semaglutide base and be able to confirm it.

Bottom line on safety: a legitimately compounded semaglutide preparation, dispensed by a US-licensed compounding pharmacy after a licensed-provider evaluation, has a similar safety profile to branded Wegovy at the same dose. Outcomes are individual. A licensed provider must review your full history before prescribing either one.

Sourcing: How to Spot a Legitimate Compounded Option vs Grey Market

This is the section that matters most for safety, and it is the part most cost-focused comparisons skip. Compounded semaglutide may be considered for eligible patients when prescribed by a licensed provider and dispensed by a US-licensed compounding pharmacy. Anything outside that chain is a different category of product entirely.

Green flags for a legitimate program:

• A required licensed-provider evaluation, including medical history and weight-loss appropriateness, before any prescription is issued
• A named US-licensed compounding pharmacy with a verifiable license, state, and address
• Clear disclosure that compounded medications are not FDA-approved
• LegitScript certification or equivalent third-party verification of the telehealth platform
• Use of semaglutide base, not semaglutide sodium or acetate
• Pharmacy testing for sterility, endotoxins, and potency on each lot
• A real, US-based clinical support team available by phone or message

Red flags that signal grey market:

• No prescription required, or a one-question form that approves everyone
• Labeling that says "research use only" or "not for human consumption"
• Overseas shipping, especially from regions with limited pharmaceutical oversight
• No verifiable US pharmacy license
• Prices that seem far below the legitimate compounded range
• Pressure to buy in bulk or stockpile
• No provider visit, no medical history, no follow-up structure

The cost difference between branded Wegovy and a legitimate compounded program is large enough that you do not need to shop the grey market to save money. The cost difference between a legitimate compounded program and a grey-market source is small enough that it is not worth the safety trade-off.

Dosing and Microdose Protocols

Wegovy follows a fixed titration schedule from 0.25 mg weekly up to 2.4 mg weekly as a maintenance dose, with each step lasting four weeks. Compounded semaglutide can follow the same schedule, but it also allows for flexibility that branded products do not.

The most common alternative is a microdose protocol. Microdosing starts patients at substantially lower doses than 0.25 mg weekly, often in the range of 0.05 to 0.15 mg weekly, with slower escalation. The goal is to reduce side effect intensity, support patients who are sensitive to GLP-1 effects, or maintain weight after reaching a goal at a lower ongoing dose. We have covered the rationale in detail in our microdose GLP-1 guide.

Branded Wegovy does not offer a microdose pathway. That is one of the few clinically meaningful flexibility advantages of a compounded option, and it matters most for patients who have struggled with nausea on standard titration or who have already reached their goal and want a gentler maintenance protocol.

How Madison Meds Approaches the Compounded Semaglutide Question

Madison Meds is family-owned and operates as a telehealth platform connecting eligible patients with an independent network of US-licensed providers. We do not represent providers as our staff or our clinicians. Through Madison Meds, compounded semaglutide is available to eligible patients after a licensed-provider evaluation, with the medication dispensed by a US-licensed compounding pharmacy. Pricing is bundled and posted publicly. There is no upsell pressure to escalate to a higher dose than your protocol calls for.

If you are weighing branded Wegovy against a compounded option, here is the honest framework we share with patients:

• If your insurance covers Wegovy for your indication and the copay is manageable, the FDA-approved branded product is the most regulatorily clean option, and many patients do well on it.
• If insurance has denied Wegovy or your cash cost would be more than $800 per month, a legitimate compounded program is worth a serious look. The same active ingredient, dispensed by a US-licensed compounding pharmacy, at a fraction of the cost.
• If you want a microdose start, slower titration, or a longer maintenance plan at a low dose, compounded is the only practical path. Wegovy does not offer that flexibility.
• Avoid grey-market and research-only sellers regardless of price. The savings are not worth the unknowns about the molecule, sterility, and sourcing.

What Most Comparison Pages Get Wrong

Most large FAQ pages on this topic frame the comparison as "compounded is risky, branded is safe." That framing is incomplete. The honest version is three categories, not two: branded is FDA-approved and well-studied; legitimate compounded is patient-specific preparation by a US-licensed compounding pharmacy and is not FDA-approved; grey-market is something else entirely and should be avoided. Mixing the second and third together is the most common error.

Frequently Asked Questions

Is compounded semaglutide the same as Wegovy?

Compounded semaglutide uses the same active ingredient as Wegovy and Ozempic, but it is a separately compounded preparation made by a US-licensed compounding pharmacy and is not the FDA-approved branded product. Compounded medications are not FDA-approved, and outcomes are individual.

Why is compounded semaglutide cheaper than Wegovy?

Branded Wegovy carries manufacturer, marketing, and distribution costs that compounded preparations do not. A legitimate compounded semaglutide program prices the medication, licensed-provider evaluation, and shipping together, which typically ranges from about $125 to $400 per month depending on dose and protocol.

How can I tell if a compounded semaglutide source is legitimate?

Look for a US-licensed compounding pharmacy, a required licensed-provider evaluation before any prescription, a clear address and pharmacy license disclosure, and ideally LegitScript certification. Avoid sellers that ship without a prescription or that label products "research use only."

Is compounded semaglutide safe?

When dispensed by a US-licensed compounding pharmacy after a licensed-provider evaluation, compounded semaglutide is studied in research as having a similar safety profile to branded semaglutide at equivalent doses. Common side effects are gastrointestinal. Educational content. Not medical advice. Consult licensed providers.

Will my insurance cover compounded semaglutide?

Insurance plans generally do not cover compounded medications. Many Wegovy plans also deny coverage for weight-loss indications. Most compounded semaglutide patients pay cash, and individual results vary.

Educational content. Not medical advice. Compounded medications are not FDA-approved drugs. A licensed provider in the Madison Meds network reviews your medical history before any prescription, and not all patients are appropriate candidates for GLP-1 therapy. Individual results vary. Consult licensed providers about treatment decisions.